Atb Cap Markets Forecasts Lower Earnings for Ayr Wellness

Ayr Wellness Inc. (OTCMKTS:AYRWF) – Atb Cap Markets lowered their FY2024 earnings per share (EPS) estimates for Ayr Wellness in a research report issued on Wednesday, November 13th. Atb Cap Markets analyst F. Gomes now anticipates that the company will post earnings of ($1.34) per share for the year, down from their previous forecast of ($1.15). Atb Cap Markets has a “Strong Sell” rating on the stock. The consensus estimate for Ayr Wellness’ current full-year earnings is ($1.30) per share. Atb Cap Markets also issued estimates for Ayr Wellness’ Q4 2024 earnings at ($0.29) EPS and FY2025 earnings at ($0.98) EPS.

AYRWF has been the topic of a number of other reports. Roth Mkm reduced their price objective on Ayr Wellness from $3.50 to $3.00 and set a “buy” rating on the stock in a research note on Thursday, November 14th. Roth Capital raised Ayr Wellness to a “strong-buy” rating in a research note on Friday, November 8th.

Ayr Wellness Trading Down 6.5 %

Shares of AYRWF opened at $0.72 on Monday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 0.58 and a current ratio of 1.59. The firm has a market cap of $82.19 million, a price-to-earnings ratio of -0.32 and a beta of 2.00. The firm has a 50 day moving average price of $1.77 and a 200-day moving average price of $1.96. Ayr Wellness has a fifty-two week low of $0.71 and a fifty-two week high of $4.09.

Ayr Wellness Company Profile

Ayr Wellness Inc operates as a vertically-integrated multi-state cannabis operator that cultivates, manufactures, and retails cannabis products and branded cannabis packaged goods. It owns and operates a chain of cannabis retail stores under AYR, Liberty Health Sciences, and The Dispensary brand names.